00980nas a2200385   4500000000100000008004100001260001600042653001000058653002000068653004200088653002300130653001100153653001800164653001600182653001900198653001000217653001100227653001700238653001200255653000900267653002500276653000900301653003100310100000900341700001300350700001800363700001600381700001400397700001200411245005000423856006700473300003200540490000800572022001400580       2005                            d  c2005 Nov 0110aAdult10aAnti-HIV Agents10aAntiretroviral Therapy, Highly Active10aBacterial Proteins10aBiopsy10aChaperonin 6010aChaperonins10aHIV Infections10aHIV-110aHumans10aInflammation10aleprosy10aMale10aMycobacterium leprae10aSkin10aSoutheastern United States1 aLu P1 aPatel MJ1 aYosipovitch G1 aMartiniuk F1 aCabrera A1 aLevis W00aHIV and leprosy in the Eastern United States.  uhttps://academic.oup.com/jid/article-lookup/doi/10.1086/496992  a1673-4; author reply 1674-50 v192  a0022-1899